Ponz-Sarvisé, Mariano <br/><br/>
Inhibitor of differentiation-1 as a novel prognostic factor in NSCLC patients with adenocarcinoma histology and its potential contribution to therapy resistance.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Jun 2011 
 - 4155-66 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1557-3265 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-10-3381  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--diagnosis<br/>Antineoplastic Agents--pharmacology<br/>Carcinoma, Non-Small-Cell Lung--diagnosis<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Down-Regulation<br/>Drug Resistance, Neoplasm--genetics<br/>Gene Expression Regulation, Neoplastic<br/>Gene Silencing<br/>Humans<br/>Inhibitor of Differentiation Protein 1--genetics<br/>Neoplasm Staging<br/>Prognosis<br/>RNA, Messenger--genetics<br/>RNA, Small Interfering--genetics<br/>Radiation Tolerance--genetics<br/>Treatment Outcome